Format

Send to

Choose Destination
Biomark Med. 2014;8(7):965-75. doi: 10.2217/bmm.14.71.

Biomarkers in congenital heart disease.

Author information

1
Scottish Adult Congenital Cardiac Service, West of Scotland Heart & Lung Centre, Golden Jubilee National Hospital, Clydebank, G81 4DY, UK.

Abstract

The population of adults with congenital heart disease (CHD) now exceeds the population of children with CHD. The long-term management of these patients relies on sequential assessment of anatomy and physiology and integration with symptoms, all targeted toward decision making around intervention. The advances in technology have vastly improved our assessment of anatomy and function. However, while the assessment of chronic heart failure in acquired heart disease has been revolutionized by the proven utility of cardiac biomarkers, their use in adult CHD is still being assessed.

KEYWORDS:

adult congenital heart disease; biomarkers; heart failure; heart function

PMID:
25307549
DOI:
10.2217/bmm.14.71
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center